OliX Pharmaceuticals Inc
KOSDAQ:226950
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
OliX Pharmaceuticals Inc
Other Non-Cash Items
OliX Pharmaceuticals Inc
Other Non-Cash Items Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Non-Cash Items | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
O
|
OliX Pharmaceuticals Inc
KOSDAQ:226950
|
Other Non-Cash Items
-₩9.8B
|
CAGR 3-Years
-72%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Celltrion Inc
KRX:068270
|
Other Non-Cash Items
₩265.9B
|
CAGR 3-Years
10%
|
CAGR 5-Years
4%
|
CAGR 10-Years
9%
|
|
|
SK Bioscience Co Ltd
KRX:302440
|
Other Non-Cash Items
-₩56.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
V
|
Voronoi Inc
KOSDAQ:310210
|
Other Non-Cash Items
-₩2.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Alteogen Inc
KOSDAQ:196170
|
Other Non-Cash Items
-₩20.2B
|
CAGR 3-Years
-19%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-47%
|
|
|
A
|
ABL Bio Inc
KOSDAQ:298380
|
Other Non-Cash Items
₩2.5B
|
CAGR 3-Years
-30%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
N/A
|
|
OliX Pharmaceuticals Inc
Glance View
OliX Pharmaceuticals, Inc. engages in the research and development of treatments and the manufacture and sale of new drugs. The company is headquartered in Suwon, Gyeonggi-Do and currently employs 72 full-time employees. The company went IPO on 2018-07-18. The Company’s product profile consists of OLX101, OLX102, OLX103, OLX104, OLX201, OLX301, OLX401 and others. These products are used for the treatment of hypertrophic scars and keloids, atopic dermatitis, androgenic alopecia, diabetic ulcer, age-related macular degeneration (AMD), idiopathic pulmonary fibrosis, neuropathic pain, liver fibrosis. In addition, these products are applied for skin brightening, anti-wrinkle and others. The firm operates its business within domestic market and to overseas markets.
See Also
What is OliX Pharmaceuticals Inc's Other Non-Cash Items?
Other Non-Cash Items
-9.8B
KRW
Based on the financial report for Dec 31, 2025, OliX Pharmaceuticals Inc's Other Non-Cash Items amounts to -9.8B KRW.
What is OliX Pharmaceuticals Inc's Other Non-Cash Items growth rate?
Other Non-Cash Items CAGR 3Y
-72%
The average annual Other Non-Cash Items growth rates for OliX Pharmaceuticals Inc have been -72% over the past three years .
